3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Nivolumab
18
Ipilimumab
16
pembrolizumab
15
Cyclophosphamide
13
trametinib
9
Radiotherapy
8
dabrafenib
6
Interleukin-2
6
sargramostim
5
fludarabine phosphate
5
aldesleukin
5
Vemurafenib
5
Peripheral Blood Stem Cell Transplantation
5
Fluorouracil
5
130-nm albumin-bound paclitaxel
5
fludarabine
4
Radiosurgery
4
Melphalan
4
Celecoxib
4
encorafenib
3
durvalumab
3
binimetinib
3
avelumab
3
Vorinostat
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Cytarabine
3
Capecitabine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Patient-Specific Modeling
×
Dermatologic
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn